絞り込み

16506

広告

Predicted risk of stroke and bleeding and use of oral anticoagulants in atrial fibrillation: Danish nationwide temporal trends 2011-2016.

著者 Dukanovic A , Staerk L , Fosbøl EL , Gadsbøll K , Gislason GH , Olesen JB
Thromb Res.2017 Oct 16 ; 160():19-26.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (35view , 0users)

Full Text Sources

Miscellaneous

We used Danish nationwide registries to examine temporal trends in the predicted stroke and bleeding risks (mean CHA2DS2-VASc and HAS-BLED scores per year, respectively) as well as the combination of selected stroke and bleeding risk factors per year among atrial fibrillation (AF) patients initiated for the first time between 2011 and 2016 on vitamin K antagonists (VKAs), dabigatran, rivaroxaban, or apixaban.
PMID: 29080549 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード